THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in the Merrill Lynch Global Pharmaceutical, Biotech & Medical Devices Conference on Thursday, Sept. 18, 2008, at the Merrill Lynch Financial Centre in London, beginning at 9:50 a.m. United Kingdom Time. Arvind Sood, vice president, Investor Relations for Amgen, will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, www.amgen.com, under Investors.
